Page 157 - CW E-Magazine (1-10-2024)

News from Abroad

PARTNERSHIP
ABB to provide automation solutions to Argent

LNG’s liquefaction facility in US

Swiss technology conglomerate, liquefaction technology, which focuses
ABB, has signed a Memorandum of on emission reduction and reliability.
Understanding (MoU) agreement with ABB will support this approach with its
US-based Argent LNG to collaborate Ability System 800xA integrated con-
on automation and electrical solutions trols platform, prefabricated eHouse
for a liquefaction facility at Port Four- design and analyser system solutions.
chon in Louisiana, US. Once operational,
by 2030, it is expected to produce Convenient access to established
up to 25-mtpa of liquefied natural gas from an early stage to design the system pipelines will also mean that transpor-
(LNG) helping expand US LNG export architecture to maximise operational tation costs and logistical complexities
capabilities. performance and efficiency, to enable are reduced to ensure efficient opera-
Argent LNG to adhere to emissions tions and delivery of natural gas feed-
Under the scope of the MoU, the regulations. stock to the facility. The facility will
companies will explore ABB’s plans have an initial capacity of 10-mtpa,
to deliver an integrated automation and The facility is expected to supply with a second phase adding up to an
electrical infrastructure, as well as digi- global LNG export markets including additional 15-mtpa. A smaller-scale
tal solutions including cyber security Japan, Southeast Asia, Europe, South plant will also be tailored to supply LNG
and data collection, to support Argent America and the Middle East. for next-generation LNG-powered
LNG’s efforts to develop a low carbon offshore supply vessels in the Gulf of
facility. The companies will collaborate Argent LNG will employ modular Mexico.

MILESTONE
Givaudan completes a decade in cosmetic actives

business

Givaudan, the Swiss maker of fla- portfolio with acquisitions of firms like
vours, fragrances and cosmetic ingre- Induchem, Indena, Naturex, and Alderys.
dients, recently celebrated the 10th
anniversary of its entry into the active “The 10th anniversary of Soliance’s
cosmetic ingredients business and acquisition is a testament to Givaudan’s
beauty biotechnology in Pomacle, France, dedication to continuous growth and
with the acquisition of Soliance. innovation. We are proud of the achieve-
ments made at Pomacle and remain
Over the past decade, the biotech in- cosmetic industry. “These investments committed to investing in the deve-
dustrial site in Pomacle has contributed are part of Givaudan’s broader strategy lopment of capabilities that will further
to the growth and development of the to remain at the forefront of innovation strengthen our position as the leader
Givaudan Active Beauty business, solidi- and maintain its leadership in provi- in biotech cosmetic ingredients,” said
fying its position as a key player in the ding breakthrough cosmetic solutions Mr. Gilles Andrier, CEO of Givaudan.
beauty industry. Since its acquisition, that have set new standards in the field,
Givaudan has made significant invest- including new hero molecules around “This acquisition has played a pivotal
ments in Pomacle, leveraging the human hyaluronic acid,” the company said. role in our ability to offer exceptional
skills and capabilities in biotechnology Kick-started with the acquisition of products coming from biotech to our
allowing to design, create and produce Soliance, Givaudan continued over the last customers,” noted Mr. Maurizio Volpi,
sustainably new active ingredients for the 10 years to expand its cosmetic actives President Fragrance & Beauty

Chemical Weekly October 1, 2024 157

Contents Index to Advertisers Index to Products Advertised